Following teens and adults with atopic dermatitis as they start or change systemic treatment
Follows adolescents and adults with atopic dermatitis starting or switching systemic treatments.
Key facts
- Who runs it
- Sanofi
- Where
- Albuquerque, Ann Arbor, Auburn Hills, Bakersfield, Bay City, Birmingham, Bolivar, Bountiful, Caledonia, Dallas, Detroit, Doral, Falls Church, Fargo, Fort Worth, Fremont, Gilbert, Huntersville, Kirksville, Las Vegas, Lincoln, Los Angeles, Macon, Marion, Mason, Mill Creek, Montgomery, Normal, North Chicago, North Miami Beach, Northridge, Oakland, Pflugerville, Phoenix, Pittsburgh, Pomona, Portsmouth, San Diego, Seattle, Spartanburg, Springville, Sugar Land, Warwick, Waterford, Wheat Ridge, and Winston-Salem, United StatesSee the 46 sitesAlso in 8 other countries, 36 sites
- Trial code
- NCT07290803
- U1111-1311-1824
- Registry title
- This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Status
- Recruiting
- People taking part
- 1,000 people, planned
- Started
- 17 Nov 2025
- Expected to end
- 30 Jan 2034
- Type of study
- Observational
- Record updated
- 2 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 12 and older with atopic dermatitis who are about to start a systemic treatment. It follows them in everyday care for 5 years.
- Age
- 12 years and older
- Sex
- All sexes
- Disease stage
- Confirmed atopic dermatitis (ICD-10 code L20), of any severity.
- Earlier treatment
- Must be prescribed and scheduled to start a systemic treatment for atopic dermatitis, such as biologics, oral JAK inhibitors, cyclosporine, azathioprine, methotrexate or mycophenolate mofetil.
Main reasons for not taking part
- Taking part in an interventional trial with an investigational drug that changes patient care
- Not understanding the study well enough (patient or parent/guardian)
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients aged more than or equal to (≥) 12 years at the time of consent
- Confirmed diagnosis of AD, of any severity, according to the Investigator's assessment as aligned with International Classification of Diseases 10th revision (ICD-10) code of L20
- Prescribed and scheduled to initiate any systemic treatment for AD (including but not limited to biologics, oral Janus kinase (JAK) inhibitors, cyclosporine, azathioprine, methotrexate, mycophenolate mofetil)
- Signed informed consent for registry participation by the patient or parent/legal representative and assent by the patient appropriate to the patient's age, including willingness to participate in long-term follow-up
Who cannot take part
- Concurrent participation in an interventional clinical trial that administers an investigational drug that modifies patient care
- Insufficient understanding of the study by the patient and/or parent/guardian; The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial
Where in United States
Also in 8 other countries, 36 sites
- University Of New Mexico School Of Medicine- Site Number : 8400022Albuquerque, United StatesTaking people
- David Fivenson, MD, Dermatology, PLLC- Site Number : 8400017Ann Arbor, United StatesContact: David FivensonTaking people
- Auburn Hills, MichiganHospital not named in the registryContact: Christofer BuattiTaking people
- Kern Research, Inc.- Site Number : 8400047Bakersfield, United StatesContact: Tonny TanusTaking people
- Great Lakes Research Group - Bay City- Site Number : 8400052Bay City, United StatesContact: Brent BoyceTaking people
- Cahaba Dermatology & Skin Health Center- Site Number : 8400006Birmingham, United StatesContact: Vlada GroysmanTaking people
- Red River Research Partners, Llc- Site Number : 8400054Bolivar, United StatesContact: Murphy MastinTaking people
- Cope Family Medicine - Ogden Clinic- Site Number : 8400053Bountiful, United StatesTaking people
- The Derm Institute of West Michigan- Site Number : 8400025Caledonia, United StatesContact: Kristi HawleyTaking people
- Reveal Research Institute - Dallas- Site Number : 8400012Dallas, United StatesContact: Aaron FarbergTaking people
- Wayne State University - Detroit Medical Center- Site Number : 8400035Detroit, United StatesContact: Steven DaveluyTaking people
- Doral, FloridaHospital not named in the registryContact: Gustavo TorresTaking people
- Falls Church, VirginiaHospital not named in the registryContact: Aaron FuchsTaking people
- Red River Research Partners - Fargo- Site Number : 8400037Fargo, United StatesContact: Michael BlankinshipTaking people
- Innovate Research - Fort Worth- Site Number : 8400016Fort Worth, United StatesNo longer taking part
- Center for Dermatology Clinical Research- Site Number : 8400014Fremont, United StatesContact: Sunil DhawanTaking people
- San Tan Allergy & Asthma- Site Number : 8400031Gilbert, United StatesContact: Sam Reed ShimamotoTaking people
- Piedmont Plastic Surgery and Dermatology- Site Number : 8400038Huntersville, United StatesContact: Nicole Seminara ZambrzyckaTaking people
- Kirksville, MissouriHospital not named in the registryContact: David CleaverTaking people
- Las Vegas, NevadaHospital not named in the registryContact: Harry GreenbergTaking people
- Allergy Asthma & Immunology- Site Number : 8400044Lincoln, United StatesContact: Robert SzalewskiTaking people
- Dermatology Research Associates - Los Angeles- Site Number : 8400020Los Angeles, United StatesContact: Howard SofenTaking people
- Skin Care Physicians of Georgia - Macon- Site Number : 8400034Macon, United StatesContact: David CohenTaking people
- Dermatology Associates of Mid-Ohio- Site Number : 8400026Marion, United StatesContact: George Scott DrewTaking people
- Dermatologists of Southwest Ohio - Mason- Site Number : 8400050Mason, United StatesContact: Rocco SerraoTaking people
- Frontier Dermatology Partners CRO LLC- Site Number : 8400011Mill Creek, United StatesContact: Eingun James SongTaking people
- River Region Dermatology and Laser- Site Number : 8400041Montgomery, United StatesContact: Porcia LoveTaking people
- Sneeze, Wheeze, & Itch Associates, LLC- Site Number : 8400029Normal, United StatesContact: Dareen SiriTaking people
- Rosalind Franklin University of Medicine and Science- Site Number: 8400056North Chicago, United StatesContact: Raj ChovatiyaTaking people
- Ziaderm Research, LLC- Site Number : 8400021North Miami Beach, United StatesContact: Tory SullivanTaking people
- Northridge Clinical Trials, LLC- Site Number : 8400009Northridge, United StatesContact: Navid EzraTaking people
- Sunwise Clinical Research, LLC.- Site Number : 8400010Oakland, United StatesContact: Michael Abdel MalekTaking people
- Austin Institute for Clinical Research, Inc- Site Number : 8400030Pflugerville, United StatesContact: Edward LainTaking people
- Phoenix, ArizonaHospital not named in the registryContact: Dathan HamannTaking people
- UPMC - Department of Dermatology- Site Number : 8400024Pittsburgh, United StatesContact: Joe TungTaking people
- Empire Clinical Research, LLC- Site Number : 8400007Pomona, United StatesContact: Usha ManthaTaking people
- Portsmouth, New HampshireHospital not named in the registryContact: Abel JarellTaking people
- University Clinical Trials- Site Number : 8400019San Diego, United StatesContact: Walter NahmTaking people
- University of Washington - Roosevelt Location- Site Number : 8400005Seattle, United StatesContact: Vivian ShiTaking people
- Advanced Dermatology and Cosmetic Surgery - Spartanburg- Site Number : 8400004Spartanburg, United StatesContact: Amylynne FrankelTaking people
- Springville Dermatology - Springville- Site Number : 8400055Springville, United StatesContact: Michael PetersonTaking people
- Complete Dermatology - Sugar Land- Site Number : 8400001Sugar Land, United StatesContact: Bartley GillTaking people
- Care Access Research - Warwick 2- Site Number : 8400045Warwick, United StatesContact: John ZwetchkenbaumTaking people
- Michigan Dermatology Institute - Waterford- Site Number : 8400013Waterford, United StatesContact: Cory RubinTaking people
- Western States Clinical Research, Inc.- Site Number : 8400051Wheat Ridge, United StatesContact: Jeffrey RumbyrtTaking people
- Wake Forest University Health Sciences- Site Number : 8400003Winston-Salem, United StatesContact: Steven FeldmanTaking people
About the trial
What the trial wants to find out
The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. Additionally, patient-specific factors (such as age, skin color, AD flare triggers, previous treatment responses, comorbid conditions, and the extent and site of lesions) will be assessed to better characterize the impact on the treatment journey across a broad age range and diverse geographic regions.
Read full original descriptionShow less
The study will be conducted across 10 countries in 4 different geographical regions, with a follow-up period of 5 years.
The group in the trial
- Atopic Dermatitis
This study plans to collect information on adolescent and adult patients with atopic dermatitis who initiate or switch any systemic treatment (eg, biologics, oral Janus kinase \[JAK\] inhibitors, cyclosporine, azathioprine, methotrexate, mycophenolate mofetil) for AD according to the country-specific prescribing information. During the study, investigators will prescribe medical products for treatment of AD per standard of care (SoC) and per medical judgment.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Atopic Dermatitis Disease Registry of Adult and Adolescent Patients Initiating or Switching Systemic Treatments
- Plain-language title
- Following teens and adults with atopic dermatitis as they start or change systemic treatmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 2 November 2026